PDA Initiates Quality Culture Survey
PDA surveys are designed to evaluate quality metrics practices at member organizations.
The Parenteral Drug Association (PDA) launched on Sept. 5 the first of two surveys on quality culture metrics as part the organization’s continuing program to evaluate quality metrics that can inform the regulator’s risk-based inspection programs.
A link to first survey has been sent to selected PDA members with a background or interest in pharmaceutical quality. On Sept. 6, a second survey was launched with controlled participation limited to three or four executives at selected companies. The surveys will be open for participation until Oct. 2, 2014.
PDA reports that it is conducting the 2014 PDA Quality Culture Metrics Survey to understand to what degree PDA members’ companies are measuring quality culture and to identify attributes of quality culture appropriate for use as metrics. Respondents are encouraged to base their answers on tools and approaches used at their local work site or facility, the organization reports.
Results will be presented at the 2014 PDA Pharmaceutical Quality Metrics Conference on Dec. 4, 2014 in Washington, DC.
Source: Partenteral Drug Association
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
